SEC 13F Intelligence

Aldebaran Capital, LLC / LLY

Aldebaran Capital, LLC’s Eli Lilly & Co Position

Does Aldebaran Capital, LLC own Eli Lilly & Co (LLY)? Yes — 9.0K shares worth $8M (+6.33% of its 13F portfolio) as of Q1 2026, down from 9.0K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
9.0K
% of Portfolio
+6.33%
Quarters Held
14
currently held

Position History LLY

Reported value by quarter
Q4 ’22: $3MQ4 ’22Q1 ’23: $3MQ2 ’23: $4MQ2 ’23Q3 ’23: $4MQ4 ’23: $5MQ4 ’23Q1 ’24: $6MQ2 ’24: $7MQ2 ’24Q3 ’24: $7MQ4 ’24: $6MQ4 ’24Q1 ’25: $6MQ2 ’25: $6MQ2 ’25Q3 ’25: $6MQ4 ’25: $10MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.0K$8M+6.33%
Q4 20259.0K$10M+8.70%
Q3 20257.8K$6M+5.45%
Q2 20257.8K$6M+5.99%
Q1 20257.8K$6M+6.08%
Q4 20247.8K$6M+5.71%
Q3 20247.8K$7M+6.29%
Q2 20247.8K$7M+6.56%
Q1 20247.8K$6M+5.77%
Q4 20237.8K$5M+4.64%
Q3 20237.8K$4M+4.26%
Q2 20237.8K$4M+3.77%
Q1 20237.8K$3M+2.75%
Q4 20227.9K$3M+2.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aldebaran Capital, LLC’s full portfolio or all institutional holders of LLY.